Topics
- Perdiction value of toxicity while addressing in silico and in vivo methods
- The role of ADMET in drug development
- An update on drug transporters
- Biologics v/s small molecules in ADMET
- Screening Approaches
- Predictive ADME
- And Predictive Toxicology
- Pre-clinical Screening Approaches
- Drug-Drug interactions
- Regulatory changes
Who should Attend
Vice Presidents, Chief Executives, Directors, Heads, Principle Scientists, Chief Scientists, Managers, and Project Leaders responsible for::
- Toxicology
- ADME
- PD-PK
- DMPK
- Computational modelling and simulation
- PBPK
- Computational toxicology
- Computational chemistry
- Clinical pharmacology
- Pre-clinical safety
- Drug metabolism
- Gentoxicity
- Regulatory Pharmaco-Toxicology
